Switch to:
Repros Therapeutics, Inc. (NAS:RPRX)
Cash And Cash Equivalents
$75.81 Mil (As of Dec. 2013)

Repros Therapeutics, Inc.'s quarterly cash and cash equivalents declined from Jun. 2013 ($87.70 Mil) to Sep. 2013 ($81.83 Mil) and declined from Sep. 2013 ($81.83 Mil) to Dec. 2013 ($75.81 Mil).

Repros Therapeutics, Inc.'s annual cash and cash equivalents increased from Dec. 2011 ($4.57 Mil) to Dec. 2012 ($24.21 Mil) and increased from Dec. 2012 ($24.21 Mil) to Dec. 2013 ($75.81 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Repros Therapeutics, Inc. Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 0.742.171.141.7819.471.892.964.5724.2175.81

Repros Therapeutics, Inc. Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
BS_CashAndCashEquivalents 7.074.5712.119.9429.5824.2117.1587.7081.8375.81
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide